trending Market Intelligence /marketintelligence/en/news-insights/trending/PbxZH83p6ClvzEAHHN2AYA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Recordati to buy French over-the-counter drug developer Tonipharm

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Recordati to buy French over-the-counter drug developer Tonipharm

Italy's Recordati Industria Chimica e Farmaceutica SpA will acquire France-based Tonipharm to expand its portfolio of over-the-counter products in the French market.

Tonipharm is expected to generate about €26.5 million in sales in 2018 mainly by a line of products sold under the Ginkor brand.

Financial terms of the deal were not disclosed.

The transaction is expected to close by year-end.